30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kaye Randall

Insider profile

Performance

Overall performance
1.0

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -40% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -16%
Success rate 73%
Average holding period 220
Transactions 28
Kaye Randall's trades of Longboard Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-10-16 2024-10-15 PlS Planned sale
251 +39.2%
434.87
US$1,442,163
251 +39.2% 434.87 US$1,442,163
2024-09-16 2024-09-16 PrS Proposed sale
68,727
414.40
US$4,359,639
68,727 414.40 US$4,359,639
2024-09-16 2024-09-16 PlS Planned sale
15,873 -15.8%
196.37
US$1,748,223
15,873 -15.8% 196.37 US$1,748,223
2024-09-16 2024-09-16 PlS Planned sale
1,200 -5.7%
33.12
US$39,750
1,200 -5.7% 33.12 US$39,750
2024-09-16 2024-09-16 PlS Planned sale
4,200 -16.7%
31.81
US$133,622
4,200 -16.7% 31.81 US$133,622
2024-09-16 2024-09-16 PlS Planned sale
9,366 -27.1%
30.89
US$289,278
9,366 -27.1% 30.89 US$289,278
2024-08-13 2024-08-12 PlS Planned sale
6,191 -25.7%
35.03
US$216,856
6,191 -25.7% 35.03 US$216,856
2024-08-13 2024-08-12 PlS Planned sale
10,476 -30.3%
34.55
US$361,948
10,476 -30.3% 34.55 US$361,948
2024-08-12 2024-08-12 PrS Proposed sale
16,667
35.09
US$584,845
16,667 35.09 US$584,845
2024-08-13 2024-06-25 S Sale
100 -100.0%
20.87
US$2,087
100 -100.0% 20.87 US$2,087
2024-08-13 2024-01-23 B Purchase
100 +inf%
24.82
US$2,482
100 +inf% 24.82 US$2,482